Spots Global Cancer Trial Database for A Pharmacokinetic and Efficacy Study of Amonafide L-malate (AS1413) in Combination With Cytarabine in Patients With Acute Myeloid Leukemia (AML)
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: A Pharmacokinetic and Efficacy Study of Amonafide L-malate (AS1413) in Combination With Cytarabine in Patients With Acute Myeloid Leukemia (AML)
Official Title: A Phase IIa Pharmacokinetic and Efficacy Study of Amonafide L-malate (AS1413) in Combination With Cytarabine in Adult Patients With Acute Myeloid Leukemia (AML)
Study ID: NCT01066494
Conditions
Interventions
Study Description
Brief Summary: A phase IIa study to evaluate the pharmacokinetic and efficacy of amonafide L-malate (AS1413) in combination with cytarabine in treating patients with acute myeloid leukemia (AML)
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Institute of Haematology and Transfusiology, Tbilisi, , Georgia
Medulla - Chemotherapy and Immunotherapy Clinic, Tbilisi, , Georgia
Hema - Haematology and Chemotherapy Clinic, Tbilisi, , Georgia
Institure of URgent adn Recovery Surgery n.a. V.K. gusaka of Academy Medical Science of Ukraine, Donetsk, , Ukraine
Kyiv bone Marrow Transplantation Centre, Kiev, , Ukraine
Vinnytsya Regional clinical Hospital, Vinnytsya, , Ukraine
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
